The Latest Breaking News from Eczema

IN FULL

Experts say the new tool could end ‘years of suffering for millions of patients across the UK’

Heriot-Watt said the device could help those with psoriasis and ‘revolutionise how eczema is diagnosed and treated’.

On Thursday, Sanofi SA (NASDAQ:SNY) stock tumbled after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor expectations, raising fresh doubts about the company’s ability to sustain its dermatology franchise once patent protections expire.

French drugmaker Sanofi SA (NASDAQ:SNY) stock fell sharply Thursday after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor expectations, raising fresh doubts about the company’s ability to sustain its dermatology franchise once patent protections expire.

Bye bye inflammation, hello clean, soothed skin

They would be a lifesaver for my partner with eczema

This one makeup buy changed her look for good…

For Chris Christenberry, CEO of Rejuvaskin, skin health goes beyond skincare buzzwords and marketing trends, but is rooted in medical necessity.

Evidence suggests that early exposure to family members, food, germs, dust, dirt, pollen, and pets shapes our immune response

As the number of people with allergies grows worldwide, scientists are trying to work out precisely how and why these conditions – such as asthma and eczema – develop.